- Consumer Products
- Latest 40.20
- Currency US$
- Change 0.55
- Percent Change 1.387 %
- Volume 4,928,007
- Mon Dec 9, 2013 03:37 PM EST NYSE data delayed 15 minutes.
12 months ended Sep 30, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Oct 31||$1.26||Feb 6||$1.39|
12 months ended Dec 09, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.